NDPS Act Record-Keeping: How Doctors Must Document Narcotic and Psychotropic Prescriptions

A doctor prescribing morphine for a cancer patient’s pain, or buprenorphine for opioid dependence treatment, is operating in one of the more heavily documented corners of Indian medical practice — and for good reason. The same legal framework that criminalises illicit narcotics trafficking also governs their entirely legitimate medical use, and the paperwork exists specifically so that legitimate prescribing can be clearly distinguished from diversion. This article explains what that documentation actually requires.

The Legal Foundation

The Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act), prohibits the production, possession, sale, purchase, transport, storage, or consumption of any narcotic drug or psychotropic substance outside a legally sanctioned framework. For legitimate medical use, the operative detail is in the Narcotic Drugs and Psychotropic Substances Rules, 1985, as substantially reshaped by amendments in 2014 and the accompanying 2015 rules, which were specifically designed to make it easier — not harder — for genuinely needed pain relief, palliative care, and opioid substitution therapy to reach patients, while keeping tight documentary control over how that happens.

“Essential Narcotic Drugs”: The Category That Matters Most for Clinical Practice

The 2014 amendment introduced the concept of Essential Narcotic Drugs (ENDs) — a defined category (including morphine and other opioids central to pain relief and palliative care) subject to a simplified, single central framework, replacing what had previously been a fragmented, state-by-state licensing patchwork that significantly restricted access to legitimate pain management across much of the country. This reform is directly responsible for meaningfully improving morphine and opioid availability for palliative care in India over the past decade.

Who Can Prescribe and Dispense ENDs

A recognised medical institution must specifically designate one or more registered medical practitioners to prescribe and dispense essential narcotic drugs — and that designation isn’t automatic. The designated doctor must have undergone specific training: either training in pain relief and palliative care (for prescribing ENDs for pain management), or training in opioid substitution therapy (for prescribing ENDs to treat opioid dependence). Where more than one doctor is designated within an institution, one must be specifically named as the overall in-charge, and that doctor’s name is formally endorsed on the institution’s Certificate of Recognition issued by the Controller of Drugs. Any change in the designated practitioner or overall in-charge must be reported to the Controller of Drugs within seven days.

Government and Municipal Facilities: A Simplified Pathway

Government, municipal corporation, municipal council, or Zilla Parishad hospitals and dispensaries are deemed to be recognised medical institutions for the purpose of possessing, dispensing, or selling essential narcotic drugs, provided they have at least one registered medical practitioner with the minimum qualification (a degree in medicine or dentistry) who has completed the relevant training — this simplification specifically reflects the policy goal of expanding legitimate access through the public health system.

The Specific Records Every Prescribing Doctor Must Maintain

Under Rules 52H and 52R of the NDPS Rules, a registered medical practitioner dispensing controlled drugs is required to maintain a specific set of documented records:

Form	What It Records
Form No. 3E	A separate record maintained for each individual patient
Form No. 3D	A day-to-day account of all transactions involving essential narcotic drugs
Form No. 3H	A record of all receipts and disbursements of essential drugs

Beyond an individual practitioner’s own dispensing records, hospital pharmacy protocols commonly require the prescribing consultant to write on a triplicate prescription pad specifically designed for narcotic prescriptions, with each prescription limited to a single drug name — if a patient needs multiple narcotic medications, separate prescriptions are required for each rather than combining them on one form.

Storage and Security Requirements

Facilities holding narcotic stock are generally expected to maintain a secure, dual-lock storage system, with keys held by two on-duty pharmacists rather than a single individual — a control specifically designed to prevent unilateral, undocumented access. Stock verification is typically performed every shift, with the on-duty pharmacist confirming physical stock against the recorded balance. All containers used for storing narcotic drugs must be properly labelled, and issues are tracked under a perpetual declining inventory system, meaning every dispensed unit is deducted from a running balance in real time against the corresponding prescription.

The Prescribing Doctor’s Personal Responsibility

A specific and important point in this framework: the prescribing practitioner is personally responsible where a prescription does not conform to statutory regulations — this is not simply a pharmacy compliance matter that sits with dispensing staff. A doctor issuing a narcotic prescription should treat conformity with the prescribed format and documentation requirements as their own direct professional obligation, not something that can be delegated entirely to pharmacy or administrative staff.

Retention Period

All narcotic and psychotropic substance records and registers must be maintained for a minimum of two years from the date of the last entry, and must be made available for inspection by the Commissioner of Food & Drugs Control Administration or any other authorised officer on request. This retention requirement is separate from, and shorter than, the general medical records retention guidance covered elsewhere in this series — clinics should track it as its own distinct compliance calendar item rather than assuming general record retention practices automatically cover it.

Expired Stock

Expired essential narcotic drug stock cannot simply be discarded through routine waste channels — it must be destroyed following the specific procedure set out in the Rules, generally involving documented witnessing and reporting, reflecting the same tight chain-of-custody principle that governs the drugs throughout their legitimate lifecycle.

Why This Framework Exists Alongside — Not Instead Of — Access Expansion

It’s worth understanding the underlying policy logic here: the 2014 amendment and 2015 Rules were specifically designed to expand legitimate access to pain relief and opioid substitution therapy, which had been badly constrained by a fragmented pre-2014 licensing system. The detailed record-keeping requirements are not a leftover obstacle to that goal — they are the specific mechanism that allows expanded access to coexist with strict diversion control, which is precisely why doctors managing these medications should treat the documentation as integral to, rather than separate from, providing this category of care responsibly.

A Practical Compliance Checklist

1. Confirm your institution has formally designated the required practitioner(s) for END prescribing, with the appropriate pain-relief/palliative-care or opioid-substitution-therapy training completed.
2. Maintain Forms 3E, 3D, and 3H accurately and contemporaneously, not retrospectively reconstructed.
3. Use a dedicated triplicate prescription pad for narcotic prescriptions, one drug per prescription.
4. Confirm dual-lock, dual-custody storage is in place and shift-wise stock verification is actually happening, not just documented as a formality.
5. Track the two-year record retention requirement as its own compliance item, separate from general medical record retention.
6. Report any change in designated prescriber or overall in-charge to the Controller of Drugs within the required seven-day window.

Frequently Asked Questions

Can any registered doctor prescribe essential narcotic drugs?

No. A doctor must be specifically designated by a recognised medical institution and have completed the relevant training — either in pain relief and palliative care, or in opioid substitution therapy — depending on the intended use.

Can multiple narcotic drugs be written on a single prescription?

No. Standard practice under the NDPS framework requires a prescription to contain only one drug name; multiple narcotics require separate prescriptions.

Who is responsible if a narcotic prescription doesn’t meet statutory requirements?

The prescribing practitioner is personally responsible for ensuring the prescription conforms to statutory regulations — this responsibility isn’t automatically transferred to dispensing pharmacy staff.

How long must narcotic drug records be kept?

A minimum of two years from the date of the last entry, and they must be available for inspection by the Commissioner of Food & Drugs Control Administration or another authorised officer.

Does a small private clinic need a special licence to dispense narcotic drugs to its own patients?

Generally yes — while RMPs are not typically required to obtain a licence for ordinary dispensing to their own patients, a specific licence is needed to procure, transport, stock, and dispense controlled drugs declared under the NDPS Act, distinct from routine medicine dispensing.

Researched Sources

1. Indian Kanoon — The Narcotic Drugs and Psychotropic Substances Rules, 1985 (designated practitioner provisions)
2. Consortium of Accredited Healthcare Organisations (CAHO) — Narcotic Drugs and Psychotropic Substance Usage in Hospital
3. PMC (National Library of Medicine) — Medicolegal Issues with Reference to NDPS and MHCA in Management and Rehabilitation of Persons with Substance Use Disorders
4. SoOLEGAL — Guidelines to Be Followed by Registered Medical Practitioners to Dispense Medicines

Disclaimer

This article is for general informational and educational purposes and reflects the NDPS Rules as understood at the time of writing. It is not legal advice; doctors and institutions handling narcotic or psychotropic substances should consult the current NDPS Rules directly and their institution’s licensing authority for complete, up-to-date compliance requirements.